New York, US - Oct 1, 2018 - Creative Biolabs, a leading services provider who is committed to providing high-quality services to promote the development of antibody-drug conjugates (ADCs) and other innovative targeted protein therapeutic agents, recently upgraded their advanced ADC technologies covering all crucial stages in ADC development.
As next-generation promising medicines with specific targeting ability in immunotherapy, ADCs are expected to have high potential and wide applications in treating various types of cancer, fungal or bacterial infections, cardiovascular disorders, and immune diseases. Empowered by advanced technical platforms, scientists with Ph. D levels in Creative Biolabs devote themselves to providing their clients with comprehensive services from antibody design to 3D Cell Culture.
“We have adopted a variety of strategies in antibody design and engineering to generate new monoclonal antibodies with accommodating conjugation chemistry sites for the creation of ADCs. Our team is also able to manufacture recombinant antibodies, protein conjugates, and ADCs in cGMP certified facilities. Meanwhile, 3D Cell Culture systems are adopted to help painting a more comprehensive picture of the ADC behavior under these circumstances while properly evaluating the “bystander” killing effect of an ADC in these cell clusters”, said the key scientist in Creative Biolabs.
“It is worth mentioning our DrugLnk synthesis platform to prepare customized linkers with unique structures. This special platform helps generate a successful ADC linker of >95% purity to facilitate antibody-drug conjugate (ADC) development projects. We can provide a variety of chemically versatile linker molecules, including cleavable linkers, non-cleavable linkers, and intermediate linker modules equipped with with good blood stability and highly specialized conjugation chemistry, such as SMCC.”
About Creative Biolabs
Creative Biolabs has established our leadership in targeted immunotherapy and antibody-drug conjugate (ADC) development. We offer our customers with comprehensive one-stop-shop of all aspects in ADC research and evaluation, ranging from antigen selection, antibody production/optimization, payload-linker synthesis, ADC conjugation, to various stages of ADC characterization and pre-clinical evaluation. Furthermore, our inventory also contains an extensive list of linkers, payloads, payload-linker sets, and commonly used ADCs for quick deployment and concept validation.
Media Contact
Company Name: Creative Biolabs
Contact Person: Bella Smith
Email:Send Email
Phone: 1-631-619-7922
Address:45-1 Ramsey Road
City: Shirley
State: New York
Country: United States
Website: https://www.creative-biolabs.com/adc
